tykhr
sign in
free sign up
Alkermes Plc
Drug Manufacturers - Specialty & Generic
Healthcare
ALKS
167 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
27.62
52 week high
36.00
high
29.18
52 week low
23.01
low
26.46
growth
23.12 %
previous Close
28.19
P/E ratio
market cap
4.77 B
div yield
0
usd
Sep 2024
qoq
revenue
378 M
-5.26 %
net incoming
92.38 M
1.12 %
eps
0.00 %
2.86 %
eps surprise
-2.70 %
net profit margin
24.43 %
1.00 %
operating incoming
105 M
-4.67 %
net change in cash
-138.86 M
-221.38 %
cash on hand
396 M
-25.95 %
cost of revenue
63.10 M
0.34 %
top